SLXN Company Profile and Key Details
Biomotion Sciences Ordinary Shares
SLXN Stock Price Chart
Stock Price Today
Biomotion Sciences Ordinary Shares (SLXN) stock declined over -34.71%, trading at $2.05 on NASDAQ, down from the previous close of $3.14. The stock opened at $2.24, fluctuating between $1.87 and $2.30 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Silexion Therapeutics LTD, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform. Its products comprise SiG12D-LODER that has completed pre-clinical studies and an open label Phase I clinical trial for the treatment of pancreatic cancer; Prostate-LODER, which is in pre-clinical studies for the treatment of prostate cancer; and GBM-LODER that is in pre-clinical studies to target Glioblastoma Multiform, a malignant primary brain tumor. The company was founded in 2008 and is headquartered in Jerusalem, Israel.
Company Information
| Employees | 0 |
| Beta | -0.11 |
| Sales or Revenue | N/A |
| 5Y Sales Change% | N/A |
| Fiscal Year Ends | N/A |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Biomotion Sciences Ordinary Shares (NASDAQ: SLXN) stock price is $2.05 in the last trading session. During the trading session, SLXN stock reached the peak price of $2.30 while $1.87 was the lowest point it dropped to. The percentage change in SLXN stock occurred in the recent session was -34.71% while the dollar amount for the price change in SLXN stock was -$1.09.
The NASDAQ listed SLXN is part of Biotechnology industry that operates in the broader Healthcare sector. Biomotion Sciences Ordinary Shares designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
No Data
SLXN's closing price is 890.34% higher than its 52-week low of $0.21 where as its distance from 52-week high of $13.56 is -84.88%.
Number of SLXN employees currently stands at 0.
Official Website of SLXN is: https://silexion.com
SLXN could be contacted at phone 972 267 43430 and can also be accessed through its website. SLXN operates from The Goldyne Savad Institute of Gene Therapy, Jerusalem, 9112001, Israel.
SLXN stock volume for the day was 14.02M shares. The average number of SLXN shares traded daily for last 3 months was 13.98M.
The market value of SLXN currently stands at $8.19M with its latest stock price at $2.05 and 4M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com